Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Author(s) -
Amil M. Shah,
Brian Claggett,
Nancy K. Sweitzer,
Sanjiv J. Shah,
Anita Deswal,
Inder S. Anand,
Jerome L. Fleg,
Bertram Pitt,
Marc A. Pfeffer,
Scott D. Solomon
Publication year - 2015
Publication title -
circulation heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 104
eISSN - 1941-3297
pISSN - 1941-3289
DOI - 10.1161/circheartfailure.115.002249
Subject(s) - spironolactone , ejection fraction , heart failure , cardiology , medicine , cardiac function curve , heart failure with preserved ejection fraction , stroke volume , aldosterone
Limited data exist regarding the impact of aldosterone antagonist therapy on cardiac structure and function in heart failure with preserved ejection fraction and on the prognostic relevance of changes in cardiac structure and function in heart failure with preserved ejection fraction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom